Management of Acute Uncomplicated UTIs in Adults by Community Pharmacists ([UTI])

May 26, 2022 updated by: Abdulhafiz Taofiq Tanimola, University of Ibadan

Impact of Online Counselling Training For Pharmacists on The Management of Acute Uncomplicated Urinary Tract Infections in Adults; A Double-blind Randomized Controlled Trial

This study is to be conducted in community pharmacies. It involves the use of trained mystery patients to evaluate community pharmacists at baseline and post intervention. The pharmacists will be divided into control and intervention groups using computer generated codes. Those in the intervention group will receive an online training by clinical pharmacists. The training will employ the use of didactic teaching and the use of case studies and simulations covering the diagnosis and management of acute uncomplicated urinary tract infections in adults. Post intervention, mystery patients will revisit the community pharmacists in the control and intervention groups for re-assessment.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Abdulhafiz T Taofiq, B.Pharm.
  • Phone Number: +2347063798732
  • Email: taofiq32@gmail.com

Study Contact Backup

Study Locations

  • Nigeria
    • Oyo
      • Ibadan, Oyo, Nigeria, 200284
        • Recruiting
        • University of Ibadan
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • The superintendent pharmacist, or the pharmacist manager or any other post National Youth Service Corps pharmacist

Exclusion Criteria:

  • Interns, and pharmacists undergoing the mandatory National Youth Service Corps program.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pharmacists in the intervention group
The pharmacist will be given an online educational training on management of acute uncomplicated urinary tract infections
Other: Educational training
Pharmacists in the intervention group will given detailed online educational training on how to recognize and manage acute uncomplicated urinary tract infections in adults.
No Intervention: Pharmacists in the control group
pharmacists in this group will not be trained, until after the completion of the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Questioning skill score
Time Frame: Through the study completion (an average of 6 months)
Expert Panels' Relevant Questions - Through 80% consensus the expert panel picked 50 relevant questions. The minimum score is "0" and the maximum score is "50". The higher the score the better the questioning skill.
Through the study completion (an average of 6 months)
Correct diagnosis of Acute Uncomplicated Urinary Tract Infection
Time Frame: Through the study completion (an average of 6 months)
using the Infectious Disease Society of America treatment guideline, the pharmacists should be able to reach a diagnosis of Acute Uncomplicated Urinary Tract Infection. Appropriate diagnosis will be classified as "Correct diagnosis" and inappropriate diagnosis will be classified as "Incorrect diagnosis". Proportion will be used to describe the number of community pharmacists who got the diagnosis Correct and Incorrect.
Through the study completion (an average of 6 months)
Appropriate management of urinary tract infection
Time Frame: Through the study completion (an average of 6 months)
Infectious Disease Society of America treatment guideline
Through the study completion (an average of 6 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Ibadan

Investigators

  • Study Chair: Segun J Showande, Ph.D., University of Ibadan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 21, 2022

Primary Completion (Anticipated)

September 1, 2022

Study Completion (Anticipated)

November 1, 2022

Study Registration Dates

First Submitted

May 7, 2022

First Submitted That Met QC Criteria

May 26, 2022

First Posted (Actual)

June 1, 2022

Study Record Updates

Last Update Posted (Actual)

June 1, 2022

Last Update Submitted That Met QC Criteria

May 26, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • taofiqclinical

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Urinary Tract Infections

Clinical Trials on Educational training

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe